{name}
{subtitle}
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
city
~44 mi. (Grand Forks, North Dakota, +388 more cities)
facility
Altru Cancer Center
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +2 more types
SWOG S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
city
~44 mi. (Grand Forks, North Dakota, +210 more cities)
facility
Altru Cancer Center
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~67 mi. (Fargo, North Dakota, +523 more cities)
facility
Sanford Roger Maris Cancer Center, +1 more facility
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~67 mi. (Fargo, North Dakota, +176 more cities)
facility
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 3080)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~67 mi. (Fargo, North Dakota, +454 more cities)
facility
Sanford Broadway Medical Center, +1 more facility
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types